|
|
Article: Harvard Scientific Completes Animal Toxicity Studies For FSAD -- "Female Sexual Arousal Disorder"; Results to be Presented At FSAD Conference by Dr. Irwin Goldstein.
- Article from:
- Business Wire
- Article date:
- September 23, 1998
CopyrightCOPYRIGHT 1998 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LAKE MARY, Fla.--(BUSINESS WIRE)--Sept. 23, 1998--Harvard Scientific Corp., (OTC Bul Bd: HVSF) a Nevada corporation, announced today that it is extremely pleased with the results obtained from its animal toxicity studies for its proprietary treatment product for female sexual arousal disorder ("FSAD").
In the studies, lyophilized liposomal Prostaglandin E-1 ("LLPGE1") suspended in a gel was applied to rabbit vaginas at escalating doses of 0.125 to 1.5 mg and placebo for 14-days. The studies have been completed and the results have been fully analyzed. Dr. Irwin Goldstein will present the toxicity data on behalf of the Company at Boston University School of ...